Helix ± loop ± helix proteins constitute a family of transcription factors with the potential to form homoand hetero-dimers mediated by the helix ± loop ± helix domain. Oncogenic mutations in such genes can disrupt the equilibrium of protein-protein interactions in the aected cell. In order to assess the biological consequences of such mutations, the full complement of interacting proteins must be known. To identify proteins interacting with the basic-helix ± loop ± helix domain of the ubiquitously expressed E47 protein, a`sandwich'-screening procedure was developed which distinguishes between homo-and hetero-oligomers, and speci®cally excludes the detection of complexes which cannot bind DNA. Nine distinct cDNAs were identi®ed which encode proteins with apparent basic-helix ± loop ± helix domains, including a novel clone termed eip1 which is distantly related in the basic-helix ± loop ± helix domain to the Drosophila enhancer-of-split m7 protein. Using epitopetagging, interaction of E47 basic-helix ± loop ± helix protein with the eip1 protein encoded by this novel cDNA was con®rmed by immunoprecipitation experiments in COS7 cells. Interaction was also observed in the yeast two-hybrid system. Three cDNAs encoding proteins without basic-helix ± loop ± helix domains were also found to interact in the sandwich-expression screen. Interactions with human PARP and mouse replication factor 1a were con®rmed using glutathione transferasetagged cDNAs. A cDNA encoding part of the nucleolin protein sequence interacted with the E47 basic-helix ± loop ± helix only when fused to a b-galactosidase tag.
Introduction
Helix ± loop ± helix (HLH) proteins constitute a family of transcription factors characterised by a common structural motif, the helix ± loop ± helix (Kadesch, 1993) , which mediates protein-protein interactions with the potential to form both homo-and hetero-dimers. Dimerisation juxtaposes basic regions on each protein partner immediately upstream of the HLH region forming a speci®c DNA-binding domain which can recognise the consensus DNA sequence, CANNTG, known as the E-box, present in the regulatory region of target genes (Ephrussi et al., 1985) .
Members of the basic-helix ± loop ± helix (bHLH) family have been demonstrated to be important in controlling cell proliferation and commitment. In some cases, subfamilies act at dierent points in a common dierentiation pathway, for example, during vertebrate myogenesis and Drosophila neurogenesis (Jan and Jan, 1993) . Other bHLH proteins play crucial roles in haematopoiesis (Zhuang et al., 1994; Bain et al., 1994) and sex determination (Cline, 1976) . Murre et al. (1989b) suggested three dierent classes of HLH proteins. Class A contains the ubiquitously expressed proteins while class B molecules are expressed in a lineage-restricted fashion. Class A and B molecules can interact to form dimers with high anity for speci®c DNA sequences. Class C molecules (e.g. MYC) do not form heterodimers with either class A or B molecules. A further class could now be added, comprising those HLH proteins which lack the basic region, such as Id-1 and Id-2 (Benezra et al., 1990; Sun et al., 1991) . This class is implicated in the repression of transcription by forming heterodimers which can no longer bind DNA.
An archetypical class A protein is E47, a product of the E2A gene, ®rst-identi®ed in some pro-and pre-Bcell lymphoma-associated chromosome translocations (Kamps et al., 1990; Inaba et al., 1992) . It is ubiquitously expressed albeit at varying levels (Roberts et al., 1993) , and is essential for B-cell development (Zhuang et al., 1994; Bain et al., 1994) , presumably because E47 homo-and hetero-dimers are required for activation of certain B-cell promoters. In other tissues, functional redundancy assumedly exists with E47 being replaced by other class A proteins.
E47 has been previously shown to interact with the class B bHLH proteins MyoD, myogenin and TAL1 (Hsu et al., 1994) . Interaction with these proteins forms heterodimers with high anity for speci®c target DNA sequences (Murre et al., 1989b; Hsu et al., 1991) . Consequently, E47/MyoD and E47/ myogenin dimerisation may be an important regulator of the muscle dierentiation pathway while E47/TAL1 dimerisation may regulate some aspects of haematopoiesis.
The identi®cation of lineage-speci®c dimerisation partners of E47 adds weight to the possibility that similar molecules for other lineages may exist. We have used the ability of the E47 bHLH to dimerise with speci®c bHLH proteins in a novel assay to clone bHLH proteins which may interact with E47. Furthermore, we have identi®ed three proteins, nucleolin, replication factor1a and poly(A)ribose polymerase (PARP), which are able to interact in vitro with the E47 bHLH despite the absence of a recognised bHLH domain.
Results

Development of an assay to identify and dierentiate between class A and B bHLH proteins
To identify proteins interacting with the E47 bHLH we developed a`sandwich'-screening procedure which relies on protein-protein interactions to generate speci®c DNA binding activity. Fusion proteins expressed in recombinant lgt11-infected E. coli were immobilised on duplicate nitrocellulose ®lters and incubated in the presence and absence of E47 bHLH bait' protein. This was followed by incubation with a 32 P-labelled concatamerised oligonucleotide containing the canonical E-box sequence CACGTG, a con®rmed binding sequence for some bHLH proteins (Blackwell et al., 1990) . The ®rst incubation permits the formation of E47 bHLH-protein hetero-oligomer complexes, while the second incubation enables the identi®cation of complexes, both homo-oligomers and heterooligomers, which possess the ability to bind the Ebox sequence. The technique speci®cally excludes the detection of complexes which cannot bind the DNA sequence thereby focussing attention on complexes which may be physiologically relevant transcription factors. Typical results are shown in Figure 1 . The bgalactosidase-E47bHLH fusion protein, which can bind DNA as a homodimer (class A), binds the labelled Ebox concatamer in both the presence and absence of E47 bHLH protein (Figure 1a) . In contrast, a bgalactosidase-myoDbHLH fusion protein only binds DNA in the presence of E47 bHLH in accordance with previous studies showing that MyoD is a class B bHLH protein which can only bind DNA as a heterodimer (Murre et al., 1989b) . With none of the fusion proteins was there a positive signal with an oligonucleotide containing the unrelated sequence CAAGCG (data not shown).
Cloning of E47 interaction partners
Two lgt11 libraries were used to identify E47 bHLH binding proteins, one derived from human T-cell line SUPT1 RNA and the other from day 17 mouse embryo RNA. cDNA inserts were ampli®ed by PCR from positive clones and subcloned into M13mp18. End sequences were obtained and used to search the NCBI non-redundant DNA database for homology. Of the ten phage clones binding as apparent homooligomers from the SUPT1 library, their cDNA inserts encoded for three bHLH proteins: MAX (amino acid 21 to C-terminus; VaÈ strik et al., 1993), HEB (amino acid 4 to C-terminus; Hu et al., 1992) and E12 (amino acid 385 to C-terminus; Kamps et al., 1990) , all of which have been previously shown to possess the ability to bind DNA as a homodimer (Solomon et al., 1993; Hu et al., 1992) . Forty-nine phage clones binding as apparent homo-oligomers were identi®ed in the mouse dE17 library screen, but were not characterised further.
Of the apparent obligate hetero-oligomers, 18 phage clones, corresponding to 11 distinct cDNAs, were obtained from the mouse dE17 library, and one from the SUPT1 library. Details of these clones are summarised in Table 1 . Nine of these 12 cDNAs encode proteins with apparent bHLH domains ± murine scleraxis , paraxis (Burgess et al., 1995) , dermo-1 (Li et al., 1995) and myoD (Pinney et al., 1988) ; the presumed murine homologues of HEB (Nielsen et al., 1992; Neuman et al., 1993) , E12 (Murre et al., 1989b) , AP-4 (Hu et al., 1990) and USF (Aperlo et al., 1996) ; and a novel clone β-gal-myoDbHLH β-gal-E47bHLH
E47bHLH
-+ -+ Figure 1 Activity of typical class A and class B bHLH proteins in the`sandwich'-screening assay. Recombinant lgt11 bacteriophage encoding b-gal-E47bHLH, a class A bHLH protein or b-galmyoDbHLH, a class B bHLH protein were transduced into E. coli Y1090. Plaques were transferred to IPTG-soaked nitrocellulose ®lters to induce the expression of b-gal fusion protein. Filters were incubated in the presence of (+) or absence of (7) the E47bHLH protein and subsequently incubated with 32 P-endlabelled E-Box oligonucleotide. After washing, the ®lters were exposed to X-ray ®lm. The autoradiograph indicates the b-gal fusion proteins which bind the E-box sequence as potential homodimers (b-gal-E47bHLH) or as obligate heterodimers with E47bHLH (b-gal-myoDbHLH) (Murre et al., 1989b; Sun and Baltimore, 1991) while scleraxis, paraxis, dermo-1 and HEB have been shown to interact with the E12 bHLH Quertermous et al., 1994; Li et al., 1995; Sawada and Littman, 1993; Hu et al., 1992) . Somewhat surprisingly, two class A proteins (E12 and HEB) and one class C protein (AP-4) were recovered as apparent obligate hetero-oligomer E-box binding proteins. Human E12 homodimers bind DNA poorly because of an N-terminal inhibitory domain whereas E12/E47 heterodimers bind DNA avidly (Sun and Baltimore, 1991) . As the E12 cDNA clone we recovered encodes this N-terminal inhibitory domain, it would not have bound DNA as a homodimer. AP-4 contains a bHLH domain followed by two leucine zipper domains and can bind DNA as a homodimer. However, the second leucine zipper is considered to be the dominant dimerisation motif and when it is removed, the protein is unable to bind DNA as a homodimer but can heterodimerise with E12 (Hu et al., 1990) . The AP-4 cDNA clone we isolated encodes the ®rst 130 amino acids of the AP-4 protein sequence and includes only part of the ®rst leucine zipper domain. Thus it would be unable to form homodimers but could dimerise with the E47 bHLH.
There appears to be an inconsistency in the isolation of HEB from the human SUPT1 library as an apparent homo-oligomer while the mouse homologue was isolated as an apparent obligate hetero-oligomer. The human HEB cDNA we cloned encodes all but the N-terminal 4 amino acids of the full-length protein whereas the mouse homologue lacks the N-terminal 582 amino acids. It is conceivable that within this region there is a domain which encourages self-association.
The USF homologue shows almost complete identity to the Genbank database entry for murine USF at the amino acid level (Figure 2A) . However, the cDNA diverges from the predicted protein sequence in the Nterminal 19 amino acids. This appears to be due to the presence of an intron in our USF cDNA clone which encodes the ®rst 19 amino acids of the fusion protein.
The scleraxis homologue deviated from the published sequence near the carboxy terminus ( Figure 2B ). This clone may represent an alternatively spliced transcript although the possibility that it is derived from a partially-processed RNA cannot be excluded. Eip1 shows limited homology to the Drosophila protein enhancer-of-split m7 (E(spl)m7; KlaÈ mbt et al., 1989) within the potential bHLH domain ( Figure 2C ) although the lack of homology outside this domain suggests that eip1 is not the mouse homologue of E(spl)m7. Northern analysis detected a 4.0 kb RNA transcript expressed predominantly in kidney, spleen and brain (data not shown).
Veri®cation of an interaction with the E47 bHLH
We wished to con®rm whether the proteins identi®ed in the lgt11 assay could indeed dimerise with E47 or were merely artifacts generated by the speci®c assay conditions employed. To this end, we attempted to Figure 2 Deduced amino acid sequences encoded by the USF and scleraxis homologues, and by the novel clone eip1. (A) Similarity between the predicted protein products of the USF homologue and the reported murine USF sequence (Aperlo et al., 1996) . (B) Amino acid sequence of scleraxis clone compared to that of published scleraxis amino acid sequence . Sequence of the clone is shown up until the cDNA/vector junction as there is no in-frame stop codon. (C) Deduced amino acid sequence of eip1. Region of homology with the bHLH region of the Drosophila protein E(spl)m7 (KlaÈ mbt et al., 1989 ) is indicated. Location of putative bHLH and coiled-coil domains are indicated above the relevant sequences. Amino acid numbering for lgt11 cDNAs begins with the ®rst amino acid encoded wholly by the cDNA (corresponding to nucleotide 2 of cDNA sequence). Dots indicate identical amino acids and asterisks indicate in-frame stop codons repeat the protein interactions in dierent systems, both in vitro and in vivo. First, the cDNAs were subcloned into a modi®ed pGEXKGSKS vector (Hainzl and Boehm, 1994) which directed the expression of the cDNA as a fusion protein linked to glutathione-transferase (see Materials and methods). The fusion proteins were expressed in E. coli C600, anity-puri®ed, separated by denaturing gel electrophoresis and transferred to nitrocellulose. Confirmation that a correct fusion protein had been produced was based on correct DNA sequence across the glutathione transferase-cDNA junction of the expression construct and the presence of a fusion protein of the correct size. The ®lter was then incubated with a 32 P-labelled E47 bHLH protein, washed to remove unbound protein and exposed to X-ray ®lm. Results are summarised in Table 2 . Of the eight fusion proteins generated, PARP, myoD and replication factor1a fusion proteins interacted relatively strongly with the E47 bHLH (Figure 3 ) while dermo-1 interacted weakly; there was no detectable signal for the remaining four fusion proteins, nor for glutathione transferase alone (data not shown).
The above assay relies on an interaction on nitrocellulose with immobilised protein which may, or may not, be in a native state. Consequently, we attempted to demonstrate an interaction using an in vivo system ± the yeast two-hybrid system (Chien et al., 1991) . Expression plasmids were constructed in which the E47 bHLH was fused to the GAL4 DNA-binding domain, and the cDNAs for the potential interaction partners were fused to the GAL4 transcriptionalactivation domain. Interactions were tested by cotransfection of plasmids into yeast strain Y190. Interaction of hybrid proteins will tether the GAL4 activation and DNA-binding domains, reconstituting a GAL4 transcriptional activator. This activates transcription of a lacZ reporter gene containing upstream GAL4 binding sites resulting in production of bgalactosidase, the activity of which can be assayed. Seven cDNA clones were tested and the results are summarised in Table 2 . The scleraxis and myoD fusion proteins exhibited the strongest interactions, while USF and eip1 interacted weakly.
As an alternative con®rmation of an in vivo interaction between E47 bHLH and the novel proteins eip1 and USF (neither of which have been previously demonstrated to interact with the E12/E47 bHLHs), we atttempted to co-immunoprecipitate complexes from mammalian cells. COS7 cells were co-transfected with expression plasmids which encoded the E47 bHLH fused to a 6 amino acid histidine tag, and the eip1 and USF cDNAs fused to a 10 amino acid MYC tag (see Materials and methods for details). Cells were lysed under conditions which have been previously shown not to disrupt bHLH dimers . The lysates were then immunoprecipitated with an antibody which recognises the MYC tag. The precipitates were fractionated by denaturing gel electrophoresis and blotted onto nitrocellulose. The ®lter was incubated in the presence of a Ni-NTA Conjugate, followed by chemiluminescent detection to assay for the presence of the histidine-tagged E47 bHLH. Co-immunoprecipitation of E47 bHLH protein was observed for both the eip1 and USF fusion proteins (Figure 4, lanes 4 and 6) . The co-immunoprecipitation was clearly dependent on the presence of eip1 or USF as it was not observed in COS7 cells transfected with the E47 bHLH expression plasmid alone (Figure 4 , lane 2) nor was any protein coimmunoprecipitated from COS7 cells transfected with the MYG tagged USF or eip1 cDNAs alone (Figure 4 , lanes 3 and 5).
Discussion
In order to understand how E47 normally functions, it is important to identify the E47 protein complexes Figure 3 In vitro interaction of E47 bHLH with glutathione transferase-PARP, -myoD, -dermo-1 and -replication factor1a fusion proteins. A nitrocellulose ®lter containing the indicated immobilised glutathione transferase-fusion proteins was incubated with 32 P-labelled E47 bHLH, washed to remove unbound protein and exposed to X-ray ®lm. Positions of molecular weight markers (in kilodaltons) are indicated. The expected sizes of GST fusion proteins are: GST-PARP, 75 kD; GST-myoD, 65 kD; GSTdermo1, 41 kD; GST-replication factor1a, 160 kD present in diverse cell types. E47 has been previously shown to dimerise with the class B bHLH proteins MyoD (Murre et al., 1989b; Lasser et al., 1991) , myogenin and TAL1 (Hsu et al., 1991 (Hsu et al., , 1994 . The ability of E12 and E47 to dimerise with class B bHLH proteins has been previously used to identify cell-type-speci®c protein partners. Li et al. (1995) used a two-hybrid assay with the E12 bHLH. Amongst the proteins they identi®ed were dermo-1, scleraxis and myoD, also detected in our assay. Their assay identi®ed several bHLH proteins (myogenin, MASH-1, tal-2) which we did not. This may re¯ect dierences in the systems used; ours is a functional system as the resulting heterodimers must possess Ebox-binding ability. However, numerous other explanations are possible. For example, the stability of a particular protein may vary between yeast and bacteria; the quality of the cDNA library will in¯uence the length of the encoded proteins; while the source of mRNA will dictate which bHLH genes are expressed and in what relative amounts.
Certain types of proteins interacting with E47 would not have been detected in our assay. Only obligate hetero-oligomers with DNA-binding activity were chosen for analysis so those proteins which can bind DNA both as a homo-and a hetero-oligomer with E47 were ignored. The assay also only selects for those complexes with DNA-binding potential, ignoring those HLH proteins such as Id-1 and Id-2 which dimerise with E47 to prevent its binding to DNA (Benezra et al., 1990; Sun et al., 1991) .
Several dierent assays were used in an attempt to con®rm the`sandwich' assay-positive clones. A total of eight clones were tested in the in vitro assay using bacterially-expressed glutathione transferase-linked fusion proteins immobilised on nitrocellulose. Replication factor1a, PARP, myoD and dermo-1 were positive in this assay. Of these, only myoD was also positive in the in vivo yeast assay. Yet three clones, scleraxis, USF and eip1, were positive in the yeast assay but negative in the Western blot assay. Thus the assays are not equivalent and a positive result in only one may not necessarily indicate a true, physiologically relevant interaction.
A potential problem with the in vitro assay using immobilised bacterial fusion proteins is that the products are denatured upon electrophoresis. Consequently, the proteins may not be in their native conformations. Lack of a correctly folded bHLH domain may prevent its interaction with the E47 protein. Further, interactions identi®ed solely with this assay may be the result of a denatured protein interacting with the E47 bHLH and, consequently, of little physiological relevance. The original sandwich assay utilises b-galactosidase fusion proteins. The relatively large size of the b-galactosidase portion of the fusion protein probably prevents correct folding of the entire partner protein but it is less likely to interfere with folding of local globular domains. Thus a-helices may well be reconstituted in such fusion proteins, resulting in HLH domains when possible.
Dermo-1 and scleraxis were previously identi®ed by their ability to associate with the E12 bHLH (Li et al., 1995) . However, as they were detected in the sandwich-assay, they can clearly also associate with the E47 bHLH. This is, perhaps, not surprising given the high degreee of sequence identity between the E12 and E47 bHLH proteins. It may be that other regions of the E12 and E47 proteins dictate the selectivity of dimerisation partners. Although scleraxis was originally identi®ed as an E12 bHLH dimerisation partner , the ability of the related protein paraxis (Burgess et al., 1995) to interact has not been reported. The results reported here suggest that paraxis, like scleraxis, may dimerise with the E12/ E47 bHLH proteins. The novel clone eip1 exhibits the main criterion for class B bHLH proteins in that it functions in DNA-binding only as an obligate heterooligomer. It is also interesting to note that eip1 protein interacted strongly with E47 in COS7 cells, while only weak interaction was observed in the yeast two-hybrid assay and no interaction was detectable in Western analyses.
In addition to these bHLH proteins, three E47 bHLH-binding proteins were identi®ed which do not have a discernible bHLH. Similarly, other assays have also identi®ed potential E12/E47 interaction partners which lack a discernible bHLH domain (Li et al., 1995) . Replication factor1a and PARP were con®rmed to interact with E47 bHLH in vitro although the in vivo yeast assay failed to reveal an interaction. Consequently, it is presently unclear whether these proteins interact in vivo with E47.
In conclusion, our results add two new members to the list of E47 interaction partners ± the recently described mouse USF and the novel gene, eip1. AP-4, PARP, replication factor1a and nucleolin are potentialy interaction partners although con®rmation awaits replication of their E47 bHLH-binding ability in alternative assays. From our data, it appears that the full complement of E47 interaction partners is still not known and will only be revealed through the use of dierent and complementary detection systems. Thè sandwich' assay described here is a useful addition to this armamentarium. Our results also reinforce the notion that disruption of protein interaction equilibria as a consequence of oncogenic mutations of E47 will result in a complex pattern of transcriptional changes involving numerous target genes. Clearly, the target genes of eip1/E47 and USF/E47 complexes must now be identi®ed to be able to assess their contribution to the oncogenic phenotype.
Materials and methods
Plasmids and phage vectors
lgt11 Libraries were constructed with the Timesaver cDNA Synthesis Kit (Pharmacia Biotech) using poly(A + ) RNA obtained from the human T-cell line SUP-T1 (Baer et al., 1987) or from 17-day-old mouse embryos. The lgt11E47bHLH recombinant used in the development of the sandwich assay (Hainzl and Boehm, 1994 ) contained a cDNA encoding amino acids 329 ± 397 of human E47 (Murre et al., 1989a) fused in-frame with the bgalactosidase gene; the lgt11myoDbHLH cDNA insert encoded amino acids 109 ± 165 of mouse myoD (Davis et al., 1987) .
Glutathione-transferase expression plasmids The construction of the pGEX-KG-SKS plasmid encoding the glutathione transferase-E47bHLH fusion protein has been described (Hainzl and Boehm, 1994) . It encodes a protein consisting of glutathione transferase fused to the E47 bHLH. lgt11 cDNAs encoding potential interaction partners were expressed as glutathione transferase fusion proteins by subcloning into a modi®ed pGEX-KG-SKS vector into which a NotI restriction site had been inserted between the NcoI and XhoI sites. The sequence of this modi®ed vector, reading from the NcoI site to the XhoI site is 5'-CCATGGGAGCGGCCGCGGCACTCGAG-3' (NotI site underlined). The NotI site is positioned such that the cDNA reading frame used in both lgt11 and this plasmid vector are the same.
Yeast plasmids pAS2-1 and pACT2 were included in the Matchmaker Two-Hybrid System 2 (Clontech). pAS2-E47bHLH was constructed by inserting a partial cDNA encoding the E47 bHLH into the NcoI and XhoI sites of pAS2-1. The plasmid encodes a fusion protein consisting of the E47 bHLH downstream of the GAL4 DNA-binding domain. cDNAs for potential interaction partners were ampli®ed by PCR and cloned into the NcoI and XhoI sites of pACT2 with the exception of eip1, which was cloned into the BamHI and EcoRI sites. The resulting plasmids were veri®ed by DNA sequencing and encode the interaction partners downstream of the GAL4 activation domain.
COS cell expression plasmids Immunoprecipitation experiments utilised two vectors which are modi®ed versions of the eukaryotic expression vector pEF-BOS (Mizushima and Nagata, 1990) . pEF-BOSHIS encodes an initiating methionine, a string of six histidine amino acids, and the SV40 large T nuclear localisation signal. This is immediately followed by a NotI site into which the cDNA is inserted and is positioned such that the reading frame used will be the same as that used to produce the bgalactosidase fusion protein in lgt11. The vector was constructed by removal of the XbaI stuer fragment from pEF-BOS and replacement with the oligonucleotide 5'-TCTAGAC CATGCATCAC CACCATCACCACGGTAG-TGGCGACGAAGTGAAGC GGAAGAAGAAGCCCTG-TGCGGCCGCTAGCTAGTCTAGA-3' (NotI site underlined). The encoded amino acid sequence up to the NotI site reads MHHHHHHGSGDEVKRKKKPC. A cDNA encoding the E47 bHLH was inserted into the NotI site to form the plasmid pEFBOSHIS-E47bHLH. pEF-BOS9E10 encodes an initiating methionine, a 10 amino acid epitope recognised by the 9E10 antibody (the so-called MYC tag, Evan et al., 1985) , and a nuclear localisation signal, followed by an in-frame NotI site. For the construction of this vector the XbaI stuer fragment was replaced with the oligonucleotide 5'-TCTAGACCATGGAGCA-GAAGC TGATCTCCGAGGAG GACCTGAACAT GGG-TAGTGGCGACGAAGTGAAGCGGAAGAAGAAGCC-CTGTGCGGCCGCTAGCTAGTCTAGA-3' (NotI site underlined). The encoded amino acids up to the NotI site read MEQKLISEEDLNMGSGDEVKRKKKPC (MYC tag underlined). The eip1 and USF cDNAs were directly subcloned from lgt11 vector into the NotI site to form pEFBOS9E10-eip1 and pEFBOS9E10-USF respectively.
Preparation of glutathione sepharose fusion proteins
Plasmids were transformed into E. coli C600 and fusion proteins puri®ed by anity chromatography on glutathione-sepharose beads (Pharmacia Biotech) as previously described (Hainzl and Boehm, 1994) .
Sandwich screening E. coli Y1090 were infected with recombinant lgt11 bacteriophage and grown overnight at 378C on agar plates. Plates were then incubated for 3 h at 428C, overlaid with a Hybond-C super nitrocellulose ®lter (Amersham) which had been presaturated in 10 mM IPTG, and incubated at 378C for 8 ± 12 h. Filters were removed and washed for 30 min at 48C in Prewash Buer (20 mM HEPES, pH 7.7, 75 mM KCl, 0.1 mM EDTA, 2.5 mM MgCl 2 , 2 mM DTT) containing proteinase inhibitors (0.2 mM phenylmethylsulphonyl¯uoride, 1 mg/ml pepstatin, 1 mg/ml leupeptin, 1 mg/ml aprotinin) followed by blocking for 2 h at 48C in Incubation Buer 1 (20 mM HEPES, pH 7.7, 150 mM KCl, 0.1 mM EDTA, 2.5 mM MgCl 2 , 2 mM DTT, 10% (v/v) glycerol, 0.1% (v/v) NP40, 0.5% (w/v) BSA, proteinase inhibitors as above). Filters were then incubated in Incubation Buer 2 (as Incubation Buer 1 but with 1% (v/v) NP40 and 0.1% (w/v) BSA) containing 5 mM puri®ed glutathione transferaseE47bHLH fusion protein for 8 h at 48C with gentle agitation. Unbound protein was removed by four washes for 1 min each in Incubation Buer 3 (as Incubation Buer 2 but with 50 mM KCl). Filters were then incubated in Incubation Buer 3 containing 5 mg/ml 32 P-labelled doublestranded E-box oligomer 5'-GGCCGCAGCACGTGGCA-CAGCACGTGGCACAGCACGTGGCAGC-3' (E-boxes underlined) for 8 ± 10 h at 48C. Unbound DNA was removed by brie¯y dipping ®lters three times in Incubation Buer 3. Filters were air-dried and exposed to X-ray ®lm overnight at 7808C. Positive plaques were picked and rescreened.
Western-blot protein interaction
Approximately 1 mg puri®ed glutathione transferase fusion protein for each potential interaction partner was separated by denaturing polyacrylamide gel electrophoresis and transferred to Hybond-C super nitrocellulose as previously described (Hainzl and Boehm, 1994) . Filters were washed for 30 min at 48C in Prewash Buer followed by blocking for 2 h at 48C in 20 mM HEPES, pH 7.7, 150 mM KCl, 2.5 mM MgCl 2 , 0.1 mM EDTA, 2 mM DTT, 10% (v/v) glycerol, 0.1% (v/v) NP40, 5% (w/v) BSA, 5% (w/v) non-fat skim milk powder, proteinase inhibitors and then incubated overnight at 48C in Interaction Buer (as above but with 0.5% (w/v) BSA and 0.5% (w/v) non-fat skim milk powder) containing 250 ng E47 bHLH protein labelled with 32 P by heart muscle protein kinase as previously described (Hainzl and Boehm, 1994) . Filters were washed three times for 10 min each in 20 mM HEPES, pH 7.7, 150 mM KCl, 0.1 mM EDTA, 2.5 mM DTT, 10% (v/v) glycerol, 0.1% (v/v) NP40, air-dried and exposed to X-ray ®lm.
Yeast interactions
pAS2-E47bHLH was transformed into yeast strain Y190, and plated out on synthetic medium lacking tryptophan. Plates were incubated for 4 days at 308C. Positive colonies were restreaked on fresh SD-trp plates and used for subsequent transformations. This was done independently with each of the pACT2-cDNA target plasmids and the cells were plated on synthetic medium lacking tryptophan and leucine. Alternatively, Y190 was simultaneously cotransformed with pAS2-E47bHLH and each of the pACT2-cDNAs with equivalent results (data not shown). After incubation at 308C for 4 days, colonies were assayed for bgalactosidase activity using both the plate and liquid assay procedures as described in the Matchmaker Two-Hybrid System 2 protocols (Clontech).
Immunoprecipitation 1610 7 COS7 cells were transfected with either pEF-BOSHIS-E47bHLH alone or in combination with pEF-BOS9E10-eip1 or pEFBOS9E10-USF by electroporation. After 48 h, cells were washed three times in phosphatebuered saline and nuclei isolated as previously described . Nuclei were resuspended in 350 ml Extraction Buer (10 mM HEPES, pH 7.6, 250 mM NaCl, 0.25% (v/v) NP40, 5 mM EDTA, proteinase inhibitors as above) and 100 ml 50% (w/v) protein A-sepharose beads (Pharmacia Biotech) were added. After incubation for 1 h at 48C with gentle rocking, the beads were removed by brief centrifugation and 1 mg of the mouse anti-c-myc antibody 9E10 (Pharmingen) added to the cleared supernatant, followed by incubation for a further 1 h at 48C. 1 mg rabbit anti-mouse IgG (Jackson Immunochemicals) was then added. After incubation at 48C for 1 h, 100 ml 50% (w/v) protein A-sepharose beads (Pharmacia Biotech) were added, followed by incubation for 1 h at 48C. The beads were pelleted by brief centrifugation and washed four times in 1 ml Extraction Buer, resuspended in 30 ml 16SDS loading buer and boiled for 5 min. Beads were removed by brief centrifugation and the supernatant retained. 15 ml of the supernatant were separated by electrophoresis in a 10% (w/v) denaturing polyacrylamide gel and electroblotted onto Hybond-C super nitrocellulose. 66His-tagged proteins were detected by incubating the ®lter with Ni-NTA alkaline phosphatase conjugate (Qiagen) followed by chemiluminescent detection using the Western-light system (Tropix) according to the manufacturer's instructions.
